Reckitt Benckiser Shares (LON: RKT) Hit Multi Year Low

Shares of Reckitt Benckiser Group (LON:R KT) experienced a significant drop during trading today, down 8.67% at the time of writing. The daily range of RKT so far has a low 4,034p, also a new 52 week and decade long low.

This lively trading session came on the heels of an update in the Abbott's baby formula case, with the awarding $495 million in compensation.

There is also an updated price target from Berenberg Bank, which raised from 5,100 to 5,200, maintaining a “hold” rating on the stock.

Reckitt Benckiser Group is a prominent player in the global market, with a sizeable market capitalisation of £28.78 billion and registering a P/E ratio of 1,976.21. The company is also known for its stability with a low beta of 0.06, indicating minimal volatility relative to the overall market.

Investors and shareholders can look ahead to a scheduled dividend, which was disclosed at 80.40p per share, delivering a yield of 1.82%. This dividend is slated for distribution on Friday, September 13th.

With a diverse portfolio of health, hygiene, and nutritional products, Reckitt Benckiser Group is the name behind many well-known brands such as Dettol, Durex, Gaviscon, and Nurofen. While the company's stock performance on Monday indicates a downturn, the robust trading volume and insider transactions suggest a keen interest in the company's future directions.